|
February 7, 2018 Please subscribe rate and review and check out the http://www.newfdaapprovals.com website! 1:24 Mesa Biotech Receives FDA 510(k) Clearance and CLIA Waiver for Its Accula™ Point of Care Flu A/Flu B Test https://www.prnewswire.com/news-releases/mesa-biotech-receives-fda-510k-clearance-and-clia-waiver-for-its-accula-point-of-care-flu-aflu-b-test-300594700.html 3:34 Grifols HyperRAB® (rabies immune globulin [human]) 300 IU/mL Receives FDA Approval to Treat Patients Exposed to Rabies Virus Infection https://www.prnewswire.com/news-releases/grifols-hyperrab-rabies-immune-globulin-human-300-iuml-receives-fda-approval-to-treat-patients-exposed-to-rabies-virus-infection-300594182.html 5:55 Duchenne Cell Therapy CAP-1002 Wins RMAT Designation From FDA, Capricor Says https://musculardystrophynews.com/2018/02/06/fda-grants-rmat-designation-to-cap-1002-for-dmd/ https://globenewswire.com/news-release/2018/02/05/1333106/0/en/Capricor-Receives-FDA-Regenerative-Medicine-Advanced-Therapy-RMAT-Designation-for-Duchenne-Muscular-Dystrophy-Therapy.html 8:00 FDA Expands Indication for Anemia Drug Feraheme https://www.medscape.com/viewarticle/892380 http://www.amagpharma.com/news/amag-pharmaceuticals-announces-fda-approval-of-supplemental-new-drug-application-snda-for-feraheme-ferumoxytol-injection/ 9:47 AI Medicine podcast. Type in “Emma Nichols” into iTunes or go to http://www.aimedicinenews.com In this episode I talk with Carla Leibowitz, who is the head of Strategy and Marketing at Arterys, a company that has used AI to develop a cloud based platform. Currently they have applications for cardiology, lung cancer and liver cancer. |